114 related articles for article (PubMed ID: 32454975)
1. Predictors for upstaging of ductal carcinoma
Oda G; Nakagawa T; Ogawa A; Kumaki Y; Hosoya T; Sugimoto H; Ishiba T; Mio M; Fujioka T; Kubota K; Onishi I; Uetake H
Mol Clin Oncol; 2020 Jul; 13(1):67-72. PubMed ID: 32454975
[TBL] [Abstract][Full Text] [Related]
2. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
Venkatesh SL; Oseni TO; Bahl M
Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
[TBL] [Abstract][Full Text] [Related]
4. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
5. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
6. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Kondo T; Hayashi N; Ohde S; Suzuki K; Yoshida A; Yagata H; Niikura N; Iwamoto T; Kida K; Murai M; Takahashi Y; Tsunoda H; Nakamura S; Yamauchi H
J Surg Oncol; 2015 Oct; 112(5):476-80. PubMed ID: 26346047
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
Mustafa RE; DeStefano LM; Bahng J; Yoon-Flannery K; Fisher CS; Zhang PJ; Tchou J; Czerniecki BJ; De La Cruz LM
Ann Surg Oncol; 2017 Oct; 24(10):2999-3003. PubMed ID: 28766212
[TBL] [Abstract][Full Text] [Related]
8. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
[TBL] [Abstract][Full Text] [Related]
9. Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.
Sato Y; Kinoshita T; Suzuki J; Jimbo K; Asaga S; Hojo T; Yoshida M; Tsuda H
Breast Cancer; 2016 Sep; 23(5):761-70. PubMed ID: 26324092
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma
Si J; Yang B; Guo R; Huang N; Quan C; Ma L; Xiu B; Cao Y; Tang Y; Shen L; Chen J; Wu J
Cancer Biol Med; 2019 May; 16(2):312-318. PubMed ID: 31516751
[TBL] [Abstract][Full Text] [Related]
11. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
[TBL] [Abstract][Full Text] [Related]
12. Lesion Size on Ultrasonography Predicts Potential Invasion in Ductal Carcinoma in situ Preoperatively Diagnosed by Breast Needle Biopsy.
Shimoyama K; Osako T; Mitsuhashi T; Akiyama F; Iwase T
Acta Med Okayama; 2017 Jun; 71(3):233-240. PubMed ID: 28655943
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
Sorrentino L; Sartani A; Bossi D; Amadori R; Nebuloni M; Truffi M; Bonzini M; Riggio E; Foschi D; Corsi F
Breast J; 2018 May; 24(3):325-333. PubMed ID: 29024241
[TBL] [Abstract][Full Text] [Related]
14. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
[TBL] [Abstract][Full Text] [Related]
15. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
16. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
17. Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ.
Munck F; Clausen EW; Balslev E; Kroman N; Tvedskov TF; Holm-Rasmussen EV
Br J Surg; 2020 Jan; 107(1):96-102. PubMed ID: 31823362
[TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH
Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119
[TBL] [Abstract][Full Text] [Related]
19.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Mol Clin Oncol; 2017 Aug; 7(2):183-187. PubMed ID: 28781782
[TBL] [Abstract][Full Text] [Related]
20. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]